Photosensitizing effects of hypericin on head neck squamous cell carcinoma in vitro
- 1 April 2014
- journal article
- Published by Springer Nature in European Archives of Oto-Rhino-Laryngology
- Vol. 272 (3) , 711-718
Abstract
Clinical outcome of patients suffering from head neck squamous cell carcinomas is still poor due to recurrent disease and surgical limitations. There is still a demand for multimodality approaches and new therapeutic options. Hypericin is a promising phototoxic drug which was investigated for its effects on head neck squamous cell carcinoma cells in vitro. FaDu cells incubated with or without hypericin were illuminated (450–700 nm, 50,000 lx) for different time periods. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide- and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling assay were used to score metabolic and apoptotic activity. Even after the shortest illumination FaDu cells incubated with hypericin showed massive reduction of metabolism and excessive apoptosis. This was present even with the lowest hypericin concentration. Cells without hypericin or without illumination were not affected. These photosensitizing effects of hypericin could be suitable for clinical application and could lead to the development of an intraoperative photodynamic therapy of head neck squamous cell carcinomas.Keywords
This publication has 39 references indexed in Scilit:
- Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer ApplicationsJournal of Cancer, 2013
- Effects of hypericin and a chlorin based photosensitizer alone or in combination in squamous cell carcinoma cells in the darkPhotodiagnosis and Photodynamic Therapy, 2012
- Hypericin for visualization of high grade gliomas: First clinical experienceEuropean Journal of Surgical Oncology, 2012
- New Frontier in Hypericin-Mediated Diagnosis of Cancer with Current Optical TechnologiesAnnals of Biomedical Engineering, 2011
- The application and challenges of clinical PD–PDT in the head and neck region: A short reviewJournal of Photochemistry and Photobiology B: Biology, 2010
- Cellular and Molecular Mechanisms of Photodynamic Hypericin Therapy for Nasopharyngeal Carcinoma CellsThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patientsHead & Neck Oncology, 2010
- Hypericins as Potential Leads for New TherapeuticsInternational Journal of Molecular Sciences, 2010
- Clinical application of fluorescence endoscopic imaging using hypericin for the diagnosis of human oral cavity lesionsBritish Journal of Cancer, 2009
- A new human cell line (FaDu) from a hypopharyngeal carcinomaCancer, 1972